Proteomic analysis of MOLT-4 cells treated by valproic acid

. 2007 Sep ; 303 (1-2) : 53-61. [epub] 20070411

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid17426928

The effect of valproic acid (VA) on protein expression in human T-lymphocytic leukemia cells MOLT-4 was studied. VA is an inhibitor of histonedeacetylases and has a potential use as antitumor agent in leukemia treatment. The authors in this work prove that 4 h long incubation with 2 mmol/l VA causes phosphorylation of histone H2A.X and its colocalization with 53BP1 in nuclear foci. Their co-localization is typical for DSB signaling machinery. These foci were detected in cells after 4 h exposure without increase of Annexin V positive apoptotic cells. Slight increase in apoptosis (Annexin V positivity) after 24 h is accompanied by more intensive increase in phosphorylation of H2A.X and also by formation of nuclear foci containing gammaH2A.X and 53BP1. Treatment of cells with 2 mmol/l VA resulted in induction of apoptosis affecting about 30% of cells after incubation for 72 h. The changes in protein expression were examined after cell incubation with 2 mmol/l VA for 4 h. Proteins were separated by two-dimensional electrophoresis and quantified using image evaluation system. Those exhibiting significant VA-induced abundance alterations were identified by mass spectrometry. Changes in expression of 22 proteins were detected, of which 15 proteins were down-regulated. Proteomic analysis resulted in successful identification of three proteins involving alfa-tubulin 3, tubulin-specific chaperone and heterogeneous nuclear ribonucloprotein F. Expression of seven proteins was up-regulated, including heterogeneous nuclear ribonucloprotein A/B. Identified proteins are related to microtubular system and hnRNP family. Suppression of microtubular proteins and changes of balance among hnRNPs can contribute to proliferation arrest and apoptosis induction.

Zobrazit více v PubMed

EMBO J. 2001 Dec 17;20(24):6969-78 PubMed

Cancer Res. 2004 Oct 1;64(19):7144-9 PubMed

Ann N Y Acad Sci. 2006 Dec;1091:385-98 PubMed

FEBS Lett. 2001 Jun 22;499(3):199-204 PubMed

Gen Physiol Biophys. 2006 Mar;25(1):65-79 PubMed

Life Sci. 2002 Oct 18;71(22):2633-43 PubMed

Exp Cell Res. 2004 Mar 10;294(1):199-209 PubMed

Expert Opin Investig Drugs. 2004 Jan;13(1):21-38 PubMed

Appl Theor Electrophor. 1988;1(1):35-40 PubMed

Biochim Biophys Acta. 2006 Apr;1765(2):85-100 PubMed

Nature. 2002 May 23;417(6887):455-8 PubMed

DNA Repair (Amst). 2006 May 10;5(5):575-90 PubMed

J Biol Chem. 2005 Jun 17;280(24):22641-50 PubMed

J Biol Chem. 2001 Sep 28;276(39):36734-41 PubMed

Mol Cells. 2001 Aug 31;12(1):1-10 PubMed

J Biol Chem. 2001 Nov 9;276(45):42462-7 PubMed

Cancer Res. 2004 Apr 1;64(7):2390-6 PubMed

J Cell Biol. 2006 Apr 24;173(2):195-206 PubMed

Cancer Res. 2006 Jan 15;66(2):763-9 PubMed

J Proteome Res. 2006 May;5(5):1098-106 PubMed

J Cell Biol. 2000 Dec 25;151(7):1381-90 PubMed

J Cell Sci. 1992 Dec;103 ( Pt 4):953-64 PubMed

Mol Cancer Ther. 2002 Sep;1(11):937-41 PubMed

Cell Growth Differ. 2001 Feb;12(2):61-83 PubMed

Ann Hematol. 2004;83 Suppl 1:S91-2 PubMed

Mol Cancer Ther. 2003 Feb;2(2):151-63 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...